相关实验视频

Updated: Jul 11, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

前列腺癌的分子分类:个性化风险分层和精确治疗的基础

Qintao Ge^1,2,3, Jiawei Li^1,2,3, Feixiang Yang^1,2,3

¹Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China.

Annals of medicine

|November 8, 2023

概括

分子分类提供了比传统方法更好的前列腺癌 (PCa) 风险分层. 本综述探讨了这些先进的分子特征及其对个性化PCa管理的临床实用性.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
生物信息学是一种生物信息学.

背景情况:

前列腺癌 (PCa) 管理依赖瘤分类来预测结果和指导治疗.
临床病理学特征,如格里森得分是标准的,但未能捕捉PCa异质性.
分子分类正在出现,通过分析基因组和表观遗传因素来解决这些限制.

研究的目的:

审查前列腺癌现有的分子分类.
确定临床相关的分子特征.
分析八个关键分子分类的方法和临床效用.

主要方法:

对PCa中分子分类的现有文献的审查.
对基因组,表观遗传和瘤微环境数据的分析.
检查各种统计和算法方法 (例如,PAM50,集群方法).

主要成果:

分子分类揭示了PCa的特征性基因组和表观遗传改变.
与临床病理学方法相比,这些分类提供了对PCa异质性的更细致的理解.
验证研究,如NRG-GU-006中PAM50的使用,显示出临床应用的希望.

结论:

分子分类代表了前列腺癌风险分层的重大进展.
它们可以更准确地预测临床结果和个性化治疗策略.
进一步的研究和验证对于将分子分类纳入常规临床实践至关重要.

关键词:

前列腺癌是什么意思前列腺癌是什么意思分子分类的分子分类.精密处理精密处理预后预测预测预测

更多相关视频

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...